Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1995
11/02/1995WO1995028907A2 Megapoietin: a novel megakaryocyte growth promoting factor
11/02/1995WO1995028838A1 Modified amino acids for drug delivery
11/02/1995WO1995028832A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/02/1995EP0679718A2 Process for producing alpha-interferon
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679659A1 Cathepsin-l-specific inhibitor polypeptide
11/02/1995EP0679658A1 Endothelin-antagonizing peptide
11/02/1995EP0679405A1 Method for separating viruses from protein solutions
11/02/1995EP0679404A2 Use of human fibrin glue in the treatment of urinary incontinence
11/02/1995EP0679403A1 Preventive and remedy for allergic disease
11/02/1995EP0679194A1 Method to predict active growth of bacteria adhered to a surface
11/02/1995EP0679192A1 Improved recombinant production of proteins having factor viii:c activity
11/02/1995EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene
11/02/1995EP0679189A1 Cloning of enterokinase and method of use
11/02/1995EP0679187A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679185A1 Ras associated gap proteins
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679161A1 Thiazolidine derivatives, preparation thereof and drugs containing same
11/02/1995EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/02/1995EP0679153A1 Amino acids and peptides having modified terminals
11/02/1995EP0679098A1 Osseointegration promoting implant composition, implant assembly and method therefor
11/02/1995EP0679097A1 Tgf-beta formulation for inducing bone growth.
11/02/1995EP0679092A1 Cytokine restraining agents
11/02/1995EP0679091A1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization
11/02/1995EP0679090A1 Method for treating myofascial pain syndrome
11/02/1995EP0679089A1 Methods for promoting cartilage matrix formation
11/02/1995EP0679088A1 Pulmonary delivery of active fragments of parathyroid hormone
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995EP0679079A1 Solution containing igf-1
11/02/1995EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
11/02/1995EP0500901B1 Pharmaceutical compositions for use in treating parkinson's disease
11/02/1995DE4413938A1 Peptide als Therapeutikum für Autoimmunerkrankungen Peptides as therapeutics for autoimmune diseases
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188470A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995CA2188467A1 Modified amino acids for drug delivery
11/02/1995CA2188397A1 Human sperm diagnostic
11/02/1995CA2188395A1 Heparin-binding protein for the treatment of sepsis and processes for its preparation
11/02/1995CA2188391A1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/02/1995CA2188269A1 Pde iv inhibitors for treating multiple sclerosis
11/02/1995CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof
11/02/1995CA2188143A1 Use of brain natriuretic peptides (bnp), phosphorylated urodilatine, phosphorylated cdd/anp and combinations thereof
11/02/1995CA2187459A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
11/02/1995CA2177066A1 Red blood cell surrogate
11/01/1995CN1111058A Inhibitor of collagen-stimulated platelet aggregation
11/01/1995CN1110915A Method for prepn. of cerebral proteolytic liquid-cerebral health injection
10/1995
10/31/1995US5463564 System and method of automatically generating chemical compounds with desired properties
10/31/1995US5463122 Arylthio compounds
10/31/1995US5463092 Viricides
10/31/1995US5463035 Precipitation, chromatography using strongly basic anion exchange resin in borate form, crystallization
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/31/1995US5463025 Protein having human plasmin inhibiting activity
10/31/1995US5463023 Composition for inhibition of intracellular transcription
10/31/1995US5462964 Dipeptide boronic acid inhibitors of trypsin-like enzymes
10/31/1995US5462939 Treating infectious diseases, septic shock, respiratory diseases, inflammatory conditions, autoimmune diseases, bone diseases
10/31/1995US5462933 Modified bile acid conjugates, and their use as pharmaceuticals
10/31/1995US5462928 Antiarthritic agents, aids, therapy for transplant rejection
10/31/1995US5462927 Peptides aiding nerve regeneration
10/31/1995US5462926 Inhibiting inositol phosphate by contacting cells with an octapeptide
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462924 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/31/1995US5462868 Cocaine esterase from Pseudomonas sp. NCIMB 40427 for detection of cocaine
10/31/1995US5462853 Contacting samples with lectin to form specific binding complexes between the lectin and components of the sample, determining amount of the complexes, and correlating this amount to the amount of the components in the sample
10/31/1995US5462752 Inhibition of platelet binding
10/31/1995US5462751 Biological and pharmaceutical agents having a nanomeric biodegradable core
10/31/1995US5462750 Metal, ceramic or polymeric particles coated with sugars or oligonucleotides which adsorb active materials, for drug delivery or medical diagnosis
10/31/1995US5462731 Administering interleukins(or derivatives)
10/31/1995US5462726 Suppressing vasoconstriction
10/31/1995US5462535 Syringe system
10/29/1995CA2147925A1 Pseudopeptides derived from neurokinins; process for preparing the same and pharmaceutical compositions containing them
10/26/1995WO1995028494A1 Gene delivery fusion proteins
10/26/1995WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system
10/26/1995WO1995028489A1 Dihydropyrimidine dehydrogenase compositions and methods of use
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028481A1 Conserved t-cell receptor sequences
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028479A1 Process for producing dendritic cells, cells thus produced and container for carrying out this process
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028426A2 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995WO1995028425A1 Preventive for circulatory diseases
10/26/1995WO1995028424A1 Pharmaceutical peptide formulations for treatment of dust mite allergy
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028421A1 Method and product for regulating cell responsiveness to external signals
10/26/1995WO1995028420A1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/26/1995WO1995028419A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028417A1 Phosphonyldipeptides useful in the treatment of cardiovascular diseases
10/26/1995WO1995028416A1 Aziridine derivatives, their production and use
10/26/1995WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995WO1995028227A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/26/1995WO1995028178A1 Use of g-csf to reduce acute rejection
10/26/1995WO1995028174A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
10/26/1995WO1995028173A1 Treatment of congestive heart failure
1 ... 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 ... 3163